Floatz logo

Nicotine

Cardiovascular Risk Factor

Eclat Srl.Small moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cardiovascular Risk Factor cohort.

Asset / SponsorPhaseRating
Lerodalcibep
LIB Therapeutics LLC
Phase 3B
Fuzuloparib
Tulane University
Phase 1/2CCC
Zeprumetostat
Tulane University
Phase 1/2CCC
METHOTREXATE
The University of Texas at Arlington
Phase 1CC
4-OXYPIPERIDOL
The University of Texas at Arlington
Phase 1CC

View all 9 →

Same molecule, other indications

Nicotine is also rated in:

nicotine dependenceDormant
A
Indicative ·
83 / 100
View asset →
nicotine dependenceDormant
BBB
Indicative ·
73 / 100
View asset →
cognitive disorderDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →